Search Results - "Berry, Jameson T L"

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    Noncanonical Cell Death Induction by Reassortant Reovirus by Rodríguez Stewart, Roxana M, Raghuram, Vishnu, Berry, Jameson T L, Joshi, Gaurav N, Mainou, Bernardo A

    Published in Journal of virology (27-10-2020)
    “…Triple-negative breast cancer (TNBC) constitutes 10 to 15% of all breast cancer and is associated with worse prognosis than other subtypes of breast cancer…”
    Get full text
    Journal Article
  2. 2

    Enhanced Killing of Triple-Negative Breast Cancer Cells by Reassortant Reovirus and Topoisomerase Inhibitors by Rodríguez Stewart, Roxana M, Berry, Jameson T L, Berger, Angela K, Yoon, Sung Bo, Hirsch, Aspen L, Guberman, Jaime A, Patel, Nirav B, Tharp, Gregory K, Bosinger, Steven E, Mainou, Bernardo A

    Published in Journal of virology (01-12-2019)
    “…Breast cancer is the second leading cause of cancer-related deaths in women in the United States. Triple-negative breast cancer constitutes a subset of breast…”
    Get full text
    Journal Article
  3. 3

    Doxorubicin Conjugation to Reovirus Improves Oncolytic Efficacy in Triple-Negative Breast Cancer by Berry, Jameson T.L., Muñoz, Luis E., Rodríguez Stewart, Roxana M., Selvaraj, Periasamy, Mainou, Bernardo A.

    Published in Molecular therapy. Oncolytics (25-09-2020)
    “…Breast cancer is the second leading cause of cancer-related deaths in women in the United States. The triple-negative breast cancer (TNBC) subtype associates…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Current understanding of reovirus oncolysis mechanisms by Phillips, Matthew B, Stuart, Johnasha D, Rodríguez Stewart, Roxana M, Berry, Jameson Tl, Mainou, Bernardo A, Boehme, Karl W

    Published in Oncolytic virotherapy (01-01-2018)
    “…Mammalian orthoreovirus (reovirus) is under development as a cancer virotherapy. Clinical trials demonstrate that reovirus-based therapies are safe and…”
    Get full text
    Journal Article
  6. 6

    Current understanding of reovirus oncolysis mechanisms by Phillips, Matthew B, Stuart, Johnasha D, Stewart, Roxana M Rodriguez, Berry, Jameson TL, Mainou, Bernardo A, Boehme, Karl W

    Published in Oncolytic virotherapy (01-01-2018)
    “…Mammalian orthoreovirus (reovirus) is under development as a cancer virotherapy. Clinical trials demonstrate that reovirus-based therapies are safe and…”
    Get full text
    Journal Article